세계의 소동물 생체내 이미징 시장 규모는 2023년에 10억 7,000만 달러로 평가되며, 2024년 11억 5,000만 달러에서 2032년에는 21억 달러로 성장하며, 예측 기간(2025-2032년)의 CAGR은 7.8%로 성장할 전망입니다.
핵의학 이미징 기술 시장은 마이크로 MRI, 마이크로 CT, 마이크로 PET 등의 마이크로 레벨 장비, 멀티모달 이미징, 마이크로 초음파 및 광학 이미징과 같은 신기술의 발전으로 진화하고 있습니다. 시장 성장의 주요 촉진요인으로는 제약 투자 증가와 전임상 연구 수요를 들 수 있습니다. 그러나 특히 인프라와 숙련된 인력이 부족한 신흥 경제국에서는 엄격한 규제와 불충분한 상환이 문제점으로 지적되고 있습니다. 북미는 유리한 상환 정책과 첨단 이미징 시스템에 대한 막대한 투자로 세계 시장의 35%를 차지하며 선두를 달리고 있습니다. 반면, 아시아태평양은 연평균 11.5%의 견고한 성장이 예상되며, COVID-19 팬데믹은 공급망과 수요를 일시적으로 혼란에 빠뜨려 시장 역학에 영향을 미치고 있습니다. 전반적으로 저렴한 가격의 기술 상용화는 산업 확장에 계속 중요할 것입니다.
Global Small Animal Imaging In Vivo Market size was valued at USD 1.07 billion in 2023 and is poised to grow from USD 1.15 billion in 2024 to USD 2.1 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).
The nuclear imaging technology market is evolving with advancements in micro-level equipment, including micro MRI, micro CT, and micro PET, as well as multimodal imaging and emerging techniques like micro-ultrasound and optical imaging. Key drivers of market growth include increasing pharmaceutical investments and pre-clinical research needs. However, stringent regulations and inadequate reimbursement pose challenges, particularly in developing economies with insufficient infrastructure and skilled personnel. North America leads, dominating the global market with a 35% share due to favorable reimbursement policies and significant investments in advanced imaging systems. Meanwhile, the Asia-Pacific region is anticipated to experience robust growth at a CAGR of 11.5%. The COVID-19 pandemic has temporarily disrupted supply chains and demand, impacting market dynamics. Overall, affordable technology commercialization remains crucial for industry expansion.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Small Animal Imaging In Vivo market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Small Animal Imaging In Vivo Market Segmental Analysis
Global Small Animal Imaging In Vivo Market is segmented by Modality, Reagents, Application, End-User and region. Based on Modality, the market is segmented into Optical Imaging Systems, Nuclear Imaging Systems, Magnetic Resonance Imaging (MRI) Systems, Computed Tomography (CT) Systems, Ultrasound Imaging Systems and Photoacoustic Imaging Systems. Based on Reagents, the market is segmented into Optical Imaging Reagents, Nuclear Imaging Reagents, MRI Contrast Agents, Ultrasound Contrast Agents and CT Contrast Agents. Based on Application, the market is segmented into Biodistribution Studies, Cancer Cell Detection, Biomarkers, Longitudinal Studies, Drug Development and Functional and Anatomical Imaging. Based on End-User, the market is segmented into Pharmaceutical and Biotechnology Companies, Academic and Research Institutions, Contract Research Organizations (CROs) and Hospitals and Clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Small Animal Imaging In Vivo Market
The global Small Animal Imaging In Vivo market is poised for growth driven by several key factors. The increasing adoption of multimodal imaging technologies is anticipated to significantly enhance market expansion throughout the forecast period. Additionally, rising healthcare expenditures are expected to bolster the small animal imaging sector. The preference for non-invasive imaging solutions is also gaining traction, further propelling market growth. Contributing factors include higher disposable incomes and urbanization trends, which create a more conducive environment for technological advancements. Furthermore, the growing investment in healthcare infrastructure is a significant driving force, particularly in oncology applications, as cancer rates rise worldwide.
Restraints in the Global Small Animal Imaging In Vivo Market
The growth of the small animal in vivo imaging market is anticipated to be hampered by several factors during the projected period. Key restraints include the high costs associated with imaging equipment and existing technological limitations. Additionally, there is a significant shortage of skilled professionals in emerging markets, compounded by insufficient research facilities and infrastructure. The market will also encounter challenges due to low healthcare expenditure in developing countries and the absence of standardized practices. Furthermore, limited awareness and a scarcity of qualified experts will constrain the overall growth rate of the small animal imaging sector from 2022 to 2028.
Market Trends of the Global Small Animal Imaging In Vivo Market
The Global Small Animal Imaging In Vivo market is experiencing significant growth driven by the surging demand for non-invasive imaging techniques. This trend is propelled by the expansion of pharmaceutical companies and research institutions, bolstered by funding from public and private sectors for innovative developments. Moreover, advancements across multiple disciplines such as chemistry, computer science, engineering, medicine, and molecular biology are enhancing imaging capabilities. The period from 2021 to 2028 is expected to witness further opportunities, particularly due to rising demand in emerging economies and intensified R&D initiatives, positioning the market for sustained expansion and innovation.